目的观察还原型烟酰胺腺嘌呤二核苷酸氧化酶4(NOX4)抑制剂对贝伐单抗诱导人视网膜色素上皮(RPE)细胞发生上皮-间质转化(EMT)的影响。
方法将人RPE细胞系ARPE-19细胞分为空白对照组、贝伐单抗组、贝伐单抗+VAS2870组和贝伐单抗+GKT137831组,其中空白对照组不做任何处理,贝伐单抗组、贝伐单抗+VAS2870组和贝伐单抗+GKT137831组培养基中分别加入0.25 g/L贝伐单抗、0.25 g/L贝伐单抗+3 μmol/L VAS2870、0.25 g/L贝伐单抗+20 μmol/L GKT137831培养72 h,VAS2870和GKT137831均为NOX4抑制剂。采用实时荧光定量PCR和Western blot法测定NOX4和EMT标志物纤维连接蛋白(FN)、波形蛋白(Vimentin)、α-平滑肌肌动蛋白(α-SMA)及紧密连接相关蛋白闭锁小带蛋白-1(ZO-1)mRNA和蛋白表达水平;采用细胞免疫荧光染色法验证NOX4和EMT标志物蛋白在各组细胞中的表达情况。
结果实时荧光定量PCR和Western blot检测结果显示,空白对照组、贝伐单抗组、贝伐单抗+VAS2870组和贝伐单抗+GKT137831组细胞中FN、Vimentin、α-SMA、ZO-1和NOX4 mRNA和蛋白相对表达量总体比较差异均有统计学意义(mRNA: F=97.07、195.40、722.40、38.56、70.81,均 P<0.001;蛋白: F=23.09、64.58、58.19、26.97、63.19,均 P<0.001),其中贝伐单抗组FN、Vimentin、α-SMA和NOX4 mRNA和蛋白相对表达量明显高于空白对照组,ZO-1 mRNA和蛋白相对表达量明显低于空白对照组,差异均有统计学意义(均 P<0.05)。贝伐单抗+VAS2870组和贝伐单抗+GKT137831组FN、Vimentin、α-SMA和NOX4 mRNA和蛋白相对表达量明显低于贝伐单抗组,ZO-1 mRNA和蛋白相对表达量明显高于贝伐单抗组,差异均有统计学意义(均 P<0.05)。免疫荧光染色结果显示,贝伐单抗组FN、Vimentin、α-SMA荧光强度强于空白对照组,ZO-1荧光强度弱于空白对照组;贝伐单抗+VAS2870组和贝伐单抗+GKT137831组FN、Vimentin、α-SMA荧光强度弱于贝伐单抗组,ZO-1荧光强度强于贝伐单抗组。
结论NOX4参与了贝伐单抗诱导RPE细胞EMT的发生,NOX4抑制剂可减轻贝伐单抗诱导人RPE细胞的EMT程度。
ObjectiveTo observe the influence of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) 4 inhibitors on epithelial-mesenchymal transition (EMT) of human retinal pigment epithelial (RPE) cells induced by bevacizumab.
MethodsThe cultured ARPE-19 cells were divided into blank control group, bevacizumab group, bevacizumab+ VAS2870 group and bevacizumab+ GKT137831 group.Cells were cultured with 0.25 g/L bevacizumab, 0.25 g/L bevacizumab plus 3 μmol/L VAS2870 (a NOX4 inhibitor), 0.25 g/L bevaczumab plus 20 μmol/L GKT137831 (a NOX4 inhibitor) for 72 hours according to grouping.No intervention was administered to the blank control group.The mRNA and protein expression levels of NOX4 and EMT markers including fibronectin (FN), vimentin, α-smooth muscle actin (α-SMA) and tight junction related protein zonula occludens-1 (ZO-1) were measured by real-time PCR and Western blot assay, and the expression levels in different intervention groups were compared.The expressions of NOX4 and EMT markers were verified by immunofluorescence staining.
ResultsThere were statistically significant differences in the relative mRNA and protein expression levels of FN, vimentin, α-SMA, ZO-1 and NOX4 among blank control group, bevacizumab group, bevacizumab+ VAS2870 group and bevacizumab+ GKT137831 group (mRNA: F=97.07, 195.40, 722.40, 38.56, 70.81; all at P<0.001.Protein: F=23.09, 64.58, 58.19, 26.97, 63.19; all at P<0.001). The relative mRNA and protein expression levels of FN, vimentin, α-SMA and NOX4 were significantly higher and the relative mRNA and protein expression level of ZO-1 was significantly lower in bevacizumab group than those in blank control group (all at P<0.05). The relative mRNA and protein expression levels of FN, vimentin, α-SMA and NOX4 were significantly lower and the relative mRNA and protein expression levels of ZO-1 were significantly higher in bevacizumab+ VAS2870 and bevacizumab+ GKT137831 groups than those in bevacizumab group (all at P<0.05). The immunofluorescence intensity of FN, vimentin and α-SMA was stronger and the immunofluorescence intensity of ZO-1 was weaker in bevacizumab group than blank control group.The immunofluorescence intensity of FN, vimentin and α-SMA were weaker and the immunofluorescence intensity of ZO-1 was stronger in bevacizumab+ VAS2870 group and bevacizumab+ GKT137831 group than those in bevacizumab group.
ConclusionsNOX4 is involved in the bevacizumab-induced EMT of human RPE cells, the degree of which can be reduced by NOX4 inhibitors.
谢超慧,郝相慧,杨玲玲,等. NADPH氧化酶4抑制剂对贝伐单抗诱导人RPE细胞上皮-间质转化的抑制作用[J]. 中华实验眼科杂志,2022,40(06):507-513.
DOI:10.3760/cma.j.cn115989-20210407-00234版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。
徐海峰:参与选题和研究设计、研究过程指导、数据和资料分析、文章主要内容修改和定稿;谢超慧:参与研究设计和实验实施、收集和分析数据、论文撰写及修改和定稿;郝相慧:参与研究实施、收集和分析数据;杨玲玲:实验指导,对文章知识性内容的审阅和智力性内容的修改

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。